• Evaluate the epidemiologic evidence establishing EBV as a necessary factor in MS  
  • Reconcile EBV's role with the hygiene hypothesis paradox  
  • ⁠Explain proposed pathogenic mechanisms linking EBV to CNS demyelination  
  • ⁠Assess current and emerging EBV-targeted therapies  
  •  ⁠Apply this framework to clinical reasoning and patient discussions 
Session date: 
03/09/2026 - 4:00pm to 5:00pm CDT
Location: 
In-person and Virtually
1685 Highland Ave
MFCB-Room 1220
United States
See map: Google Maps
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 University of Wisconsin–Madison Continuing Education Hours
    • 1.00 Approved for AMA PRA Category 1 Credit™
Add to calendar: 
Please login or register to take this course.
Discloser List CME Internal Report